NCT05907447

A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 10,000 (estimated)
• Sponsor: Ruijin Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to retrospectively collect clinical information on patients with extranodal or rare lymphomas, and to explore the best treatment strategy for these lymphomas in the real-world population.

Detailed description

Lymphoma is a highly common malignant tumor in Asia. For specific extra-abdominal sites or rare pathological subtypes of lymphoma, traditional chemotherapy protocols often cannot provide satisfactory results for patients. This study aims to retrospectively collect clinical information on patients with extranodal lymphoma or rare pathological subtype lymphoma, including the distribution of involved sites, clinical and molecular characteristics of different lymphoma subtypes, clinical treatment protocols, and prognosis, to explore the best treatment strategy for these lymphomas in the real-world population.

Conditions

• Lymphoma
• Extranodal Lymphoma
• Diffuse Large B Cell Lymphoma
• Anaplastic Large Cell Lymphoma
• Angioimmunoblastic T-cell Lymphoma
• Marginal Zone Lymphoma
• Mucosa-Associated Lymphoid Tissue Lymphoma
• NK/T-Cell Lymphoma, Nasal and Nasal-Type
• Intravascular Large B-Cell Lymphoma

Interventions

Type	Name	Description
OTHER	No interventions need to be specified for this study	No interventions need to be specified for this study

Timeline

• Start date: 2023-07-01
• Primary completion: 2024-03-01
• Completion: 2024-10-01
• First posted: 2023-06-18
• Last updated: 2023-06-18

Locations

1 site across 1 country: China